CS
AVNR

Credit Suisse’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Credit Suisse’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-369,400
Closed -$1.36M – 4956
2014
Q1 		$1.36M Buy
+369,400
New +$1.41M ﹤0.01% 2843

Credit Suisse's AVNR Position: Q1 2015 in Review

Credit Suisse sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,651,002 shares — an estimated $28M sold.

Credit Suisse first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $28M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Credit Suisse reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Credit Suisse sold 1,651,002 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $28M.
  • Credit Suisse first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Credit Suisse's AVANIR PHARMACEUTICALS, INC CL A position peaked at $28M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.